ARCHIVES

Two Phase II Studies of Ibrutinib Deliver High Response Rates

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Cancer Research Isn’t A Priority In Bush Budget, AACR President Says.

February 9, 2007

Mack, Specter Hit White House Budget Proposal For NIH.

February 18, 2000

Investigator Initiated Clinical Research Gets More For Less Money, Carbone Contends

April 13, 1979

Clinical trials: ORI Cites Data Manager For Misconduct; Results Not Affects, NCI Says

April 2, 1999

In Washington: Health Groups Urge Congress: No Immunity For Tobacco Industry; Clinton Proposes $400M Effort To End Racial Health Disparities

February 27, 1998

Phase III Trial Shows Benefit For Old Drugs, Old Device, For Ovarian Cancer, But Will Practice Change?

January 20, 2006